Eurofins Viracor BioPharma Services

Executive Summary

Eurofins Viracor BioPharma Services (EVB) is a specialized contract research organization (CRO) headquartered in Lee's Summit, Missouri, providing comprehensive bioanalytical testing and assay development services to pharmaceutical and biotechnology companies. With a strong focus on infectious disease, vaccine safety and efficacy, immunogenicity, and precision medicine, EVB offers a range of capabilities including molecular genomic testing, next-generation sequencing (NGS), cell-based assays, allergenicity/hypersensitivity testing, and biomarker analysis. The company's custom de novo assay development and transfer services support translational research and clinical development programs for therapeutic candidates, making it a trusted partner for drug developers. Founded in 1988, EVB has established a reputation for high-quality, regulatory-compliant laboratory services that accelerate the path from preclinical to clinical stages. As part of the Eurofins Scientific network, the company benefits from global resources and expertise while maintaining operational focus in the U.S. market.

Upcoming Catalysts (preview)

• Q3 2026Potential expansion of testing services for new infectious disease targets (e.g., mpox, emerging variants)70% success
• TBDStrategic partnership with a large pharmaceutical company for vaccine clinical trial support60% success
• Q4 2026Launch of a proprietary high-throughput NGS-based assay for oncology biomarker detection50% success